Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Transcatheter Aortic Valve Implantation Indications and Patient Selection
Author(s): Jonathan Curio , Henning Guthoff , Stephan Nienaber , et al Added: 6 days ago

Vascular Disease and Surgery
Aortic Valve Calcium, Aortic Stenosis and TAVI
Author(s): James Krzowski , Jonathan Weir-McCall , Luigia D’Errico , et al Added: 1 month ago

Imaging & Diagnostics

Intervention
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 3 weeks ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
Navigating Mitral and Tricuspid Valve Disease: Diagnosis, Quality of Life, and Patient-Centered Care
Author(s): , Start date: Aug 06, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday… View more

Intervention
CRT 25: The PARTNER 3 Registry
Author(s): S. Chris Malaisrie Added: 2 months ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical… View more

Intervention
Geographical Inequality in Access to Aortic Valve Intervention in England
Author(s): Suleman Aktaa , Noman Ali , Peter F Ludman , et al Added: 9 months ago

Intervention
Gadolinium-guided Transcatheter Aortic Valve Implantation
Author(s): Bandar Alshehri , Hussein Alamri , Naif Alghasab , et al Added: 3 months ago

CV Disease in Special Populations

Intervention
New York Valves 2025
Start date: Jun 25, 2025 End date: Jun 27, 2025
New York Valves 2025 summit, sponsored by the Cardiovascular Research Foundation, is set to take place from June 25th to 27th at Jacob K. Javits Convention Center in New York. The program will offer insights into the latest practises in valvular and structural heart care. View more

Heart Failure

Intervention
Atrioventricular (AV) Valves Summit 2024
Author(s): Marco Metra , Victoria Delgado , Nicole Karam , et al Added: 7 months ago
In this series of short interviews filmed at AV Valves Summit 2024, leading experts offer valuable insights and professional opinions on transcatheter mitral and tricuspid interventions.The sessions explore a wide array of topics, including advancements in TEER techniques, the evolving focus on patient quality of life, the ongoing debate between repair versus replacement, and the most effective… View more

Vascular Disease and Surgery
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 3 weeks ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention